Status:
RECRUITING
Revascularization Effect on CSVD Burden in Carotid Artery Stenosis
Lead Sponsor:
Zhejiang Provincial People's Hospital
Conditions:
Carotid Artery Stenosis
Cerebral Small Vessel Diseases
Eligibility:
All Genders
40-80 years
Brief Summary
RECAS is a prospective cohort of 1,000 patients with carotid artery stenosis (CAS) and undergoing revascularization therapy or standard medication treatment alone. The goal of this study is to validat...
Eligibility Criteria
Inclusion
- Patients aged ≥ 40 years.
- ≥ 50% stenosis in unilateral carotid artery.
- Sign informed consent.
Exclusion
- Previous history of major head trauma and any intracranial surgery
- Intracranial abnormalities, such as intracerebral hemorrhage, subarachnoid hemorrhage, and other space occupying lesions
- Extrapyramidal symptoms or mental illness which may affect neuropsychological measurement.
- Severe loss of vision, hearing, or communicative ability.
Key Trial Info
Start Date :
June 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2034
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06031610
Start Date
June 10 2023
End Date
May 1 2034
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China, 310000